199 related articles for article (PubMed ID: 3241326)
1. [Transfer of injected sulbactam/cefoperazone into burn blister fluid].
Aoyama H; Sugiyama H; Tada M; Okuda J; Izawa Y
Jpn J Antibiot; 1988 Sep; 41(9):1279-84. PubMed ID: 3241326
[TBL] [Abstract][Full Text] [Related]
2. [Transfer of fosfomycin into human burn blister fluid and its pharmacokinetic analysis].
Koh B; Izawa Y; Sugiyama H; Aoyama H; Komiya I
Jpn J Antibiot; 1986 Nov; 39(11):2863-8. PubMed ID: 3820568
[TBL] [Abstract][Full Text] [Related]
3. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
[TBL] [Abstract][Full Text] [Related]
4. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Cho N; Watanabe H; Yoshida K; Moriyama S; Takeda H; Tsukamoto A; Fukunaga K; Kunii K
Jpn J Antibiot; 1984 Oct; 37(10):1939-55. PubMed ID: 6094873
[TBL] [Abstract][Full Text] [Related]
5. [Studies on sulbactam/cefoperazone in the field of pediatrics].
Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
[TBL] [Abstract][Full Text] [Related]
6. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H
Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
[TBL] [Abstract][Full Text] [Related]
8. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Yamamoto T; Yasuda J; Kanao M; Okada H
Jpn J Antibiot; 1984 Nov; 37(11):2213-22. PubMed ID: 6098715
[TBL] [Abstract][Full Text] [Related]
9. [Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics].
Toyonaga Y; Kurosu Y; Nakamura H; Sugita M; Takahashi T; Hori M
Jpn J Antibiot; 1984 Dec; 37(12):2457-77. PubMed ID: 6098740
[TBL] [Abstract][Full Text] [Related]
10. [Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field].
Fujii R; Meguro H; Arimasu O; Mashiko J; Tajima T; Nonaka C; Nagamatsu I; Sato Y; Honjo T; Watanabe A
Jpn J Antibiot; 1984 Dec; 37(12):2427-56. PubMed ID: 6098739
[TBL] [Abstract][Full Text] [Related]
11. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
Uete T; Matsuo K
Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
[TBL] [Abstract][Full Text] [Related]
12. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
Ito K; Kondo H; Hayasaki M; Noda K
Jpn J Antibiot; 1984 Nov; 37(11):2193-202. PubMed ID: 6098712
[TBL] [Abstract][Full Text] [Related]
13. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
Jpn J Antibiot; 1984 Oct; 37(10):1898-918. PubMed ID: 6094868
[TBL] [Abstract][Full Text] [Related]
14. [Transfer of ofloxacin into suction blister fluid after its oral administration].
Aoyama H; Sugiyama H; Ishii T; Kawauchi T; Kasuya T; Nishizaki A; Okuda J
Jpn J Antibiot; 1987 Nov; 40(11):1937-40. PubMed ID: 3481837
[TBL] [Abstract][Full Text] [Related]
15. [Fundamental and clinical studies of sulbactam/cefoperazone in the field of pediatrics].
Nakazawa S; Sato H; Narita A; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K
Jpn J Antibiot; 1984 Nov; 37(11):2174-87. PubMed ID: 6098710
[TBL] [Abstract][Full Text] [Related]
16. [Transfer of latamoxef into human burn blister fluid and its pharmacokinetic analysis].
Aoyama H; Sugiyama H; Suzuki I; Nishizaki A; Izawa Y; Oguma T; Yamada H
Jpn J Antibiot; 1985 Oct; 38(10):2821-6. PubMed ID: 4078995
[TBL] [Abstract][Full Text] [Related]
17. [Diffusion of sulbactam and cefoperazone into the prostatic tissue].
Okamura K; Hashimoto H; Morikawa M; Saga Y; Nishimoto M; Yachiku S; Osani H; Yamauchi K
Hinyokika Kiyo; 1989 Apr; 35(4):727-34. PubMed ID: 2735275
[TBL] [Abstract][Full Text] [Related]
18. [Transfer of cefmenoxime to burn blister fluids].
Nishizaki A; Aoyama H; Koh T; Izawa Y
Jpn J Antibiot; 1984 Mar; 37(3):295-302. PubMed ID: 6330396
[TBL] [Abstract][Full Text] [Related]
19. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space].
Cho N; Kimura T; Suzuki H; Fukunaga K; Kunii K; Komoriyama Y
Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980
[TBL] [Abstract][Full Text] [Related]
20. [Effects of sulbactam on the activity of cefoperazone against various clinical isolates].
Uete T; Matsuo K
Jpn J Antibiot; 1989 Apr; 42(4):896-909. PubMed ID: 2769941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
